**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 75-09-2 |Dichloromethane | 85 | 200-838-9 |
|----------------|--------------------------------------|----------|-----------|
| 87413-09-0 |Dess-Martin periodinane | 15 | unlisted |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: XN O
Risk Phrases: 40 8
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Limited evidence of a carcinogenic effect. Contact with combustible
material may cause fire.Possible risks of irreversible effects.
Potential Health Effects
Eye:
May cause eye irritation. Contact with eyes may cause severe
irritation, and possible eye burns. Causes redness and pain.
Skin:
Causes severe skin irritation. May be absorbed through the skin.
Ingestion:
Harmful if swallowed. Causes gastrointestinal irritation with
nausea, vomiting and diarrhea. May cause central nervous system
depression, characterized by excitement, followed by headache,
dizziness, drowsiness, and nausea. Advanced stages may cause
collapse, unconsciousness, coma and possible death due to respiratory
failure.
Inhalation:
Inhalation of high concentrations may cause central nervous system
effects characterized by nausea, headache, dizziness, unconsciousness
and coma. Causes respiratory tract irritation.
Chronic:
Prolonged or repeated skin contact may cause dermatitis.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Oxidizer. Greatly increases the burning rate of
combustible materials.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Use extinguishing
media most appropriate for the surrounding fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Use with adequate ventilation. Do not get on skin and clothing. Keep
container tightly closed. Keep away from heat, sparks and flame. Do
not ingest or inhale. Use only in a chemical fume hood.
Storage:
Do not store near combustible materials. Store in a tightly closed
container. Keep from contact with oxidizing materials. Store at
around 20C. Keep refrigerated. (Store below 4C/39F.)
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Local exhaust ventilation may be necessary to control any air
contaminants to within their TLVs during the use of this product.
Exposure Limits
CAS# 75-09-2:
United Kingdom, WEL - TWA: 100 ppm TWA; 350 mg/m3 TWA
United Kingdom, WEL - STEL: 300 ppm STEL; 1060 mg/m3 STEL
United States OSHA: ; 25 ppm TWA (8 hr); 125 ppm STEL (15 min); 1
ppm Action Level (See 29 CFR 1910 .1052)
Belgium - TWA: 50 ppm VLE; 177 mg/m3 VLE
France - VME: 50 ppm VME; 180 mg/m3 VME
France - VLE: 100 ppm VLE; 350 mg/m3 VLE
Germany: 100 ppm TWA; 350 mg/m3 TWA
Japan: 50 ppm OEL; 170 mg/m3 OEL
Japan: 100 ppm Ceiling; 340 mg/m3 Ceiling
Malaysia: 50 ppm TWA
Netherlands: 500 ppm STEL; 1750 mg/m3 STEL
Netherlands: 100 ppm MAC; 350 mg/m3 MAC
Russia: 50 mg/m3 TWA
Spain: 50 ppm VLA-ED; 177 mg/m3 VLA-ED
CAS# 87413-09-0:
Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula:
Molecular Weight: 424.15
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable.
Conditions to Avoid:
Incompatible materials, combustible materials.
Incompatibilities with Other Materials:
Not available.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 75-09-2: PA8050000
CAS# 87413-09-0 unlisted.
LD50/LC50:
CAS# 75-09-2: Draize test, rabbit, eye: 162 mg Moderate; Draize
test, rabbit, eye: 10 mg Mild; Draize test, rabbit, eye: 500 mg/24H
Mild; Draize test, rabbit, skin: 810 mg/24H Severe; Draize test,
rabbit, skin: 100 mg/24H Moderate; Inhalation, mouse: LC50 = 14400
ppm/7H; Inhalation, mouse: LC50 = 49100 mg/m3/6H; Inhalation, mouse:
LC50 = 54000 mg/m3/2H; Inhalation, mouse: LC50 = 56220 mg/m3/7H;
Inhalation, rat: LC50 = 52 gm/m3; Inhalation, rat: LC50 = 76000
mg/m3/4H; Inhalation, rat: LC50 = 52000 mg/m3/6H; Oral, mouse: LD50
= 873 mg/kg; Oral, rabbit: LD50 = 2000 mg/kg; Oral, rat: LD50 = 1600
mg/kg; Oral, rat: LD50 = 985 mg/kg.
CAS# 87413-09-0.
Carcinogenicity:
Dichloromethane -
ACGIH: A3 - Confirmed animal carcinogen with unknown relevance to
California: carcinogen, initial date 4/1/88
NTP: Suspect carcinogen
IARC: Group 2B carcinogen
Dess-Martin periodinane -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Ecotoxicity:
This chemical has a moderate potential to affect some aquatic
organisms. It is resistant to biodegradation, and has a low potential
to persist in the aquatic environment. 96-hr. EC50 (loss of
equilibrium);
Fathead minnow: 99mg/L; 96-hr. EC10: 66.3 mg/L.
Bluegill sunfish: 96-hr. LC50=220 mg/L;
Water flea: 24-hr.
LC50=2270 mg/L;
No observed effect level:1550 mg/L.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
No information available.
IMO
No information available.
RID/ADR
No information available.
USA RQ: CAS# 75-09-2: 1000 lb final RQ; 454 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN O
Risk Phrases:
R 40 Limited evidence of a carcinogenic effect.
R 8 Contact with combustible material may cause
fire.
Safety Phrases:
S 17 Keep away from combustible material.
S 23 Do not inhale gas/fumes/vapour/spray.
S 24/25 Avoid contact with skin and eyes.
S 36/37 Wear suitable protective clothing and
gloves.
WGK (Water Danger/Protection)
CAS# 75-09-2: 2
CAS# 87413-09-0: No information available.
Canada
CAS# 75-09-2 is listed on Canada's DSL List.
CAS# 75-09-2 is listed on Canada's Ingredient Disclosure List.
CAS# 87413-09-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 75-09-2 is listed on the TSCA inventory.
CAS# 87413-09-0 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
R 40 Limited evidence of a carcinogenic effect.
MSDS Creation Date: 9/22/1998 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
(+)-Himbacine
| 6879-74-9 |
|
Ytterbium(III) triflate hydrate, 99.9%
| 252976-51-5 |
|
Ethyl oleate, mixture of isomers, tech., 90%
| 111-62-6 |
|
Sodium hydride, 60% dispersion in mineral oil, in resealable cans
| 7646-69-7 |
|
3-(Trifluoromethyl)phenylhydrazine, tech.,, 90%
| 368-78-5 |
|
N,N'-Diaminoguanidine Monohydrochloride 98%
| 36062-19-8 |
|
Iron(III) fluoride, anhydrous, 98%
| 7783-50-8 |
|
2-Mercaptobenzothiazole, 99% (Titr.)
| 149-30-4 |
|
3-Amino-2,6-Dimethoxypyridine Monohydrochloride, 95%
| 80789-72-6 |
|
Lithium hydride, in resealable cans, 98%
| 7580-67-8 |
|
1,4-Bis(trimethylsilyl)benzene, 98%
| 13183-70-5 |
|
Carboxymethyl Cellulose, Sodium Salt, Average MW 90.000
| 9004-32-4 |
|
Carboxymethyl Cellulose, Sodium Salt, Average MW 250000 (DS=0.7)
| 9004-32-4 |
|
Carboxymethyl Cellulose, Sodium Salt, Average MW 250000 (DS=0.9)
| 9004-32-4 |
|
Carboxymethyl Cellulose, Sodium Salt, Average MW 250000 (DG=1.2)
| 9004-32-4 |
|
Carboxymethyl Cellulose, Sodium Salt, Average MW 700000
| 9004-32-4 |
|
Tyloxapol
| 25301-02-4 |
|
4-Vinylbenzyl chloride, stabilized with 500 ppm 4-tert-butylcatechol
| 1592-20-7 |
|
Ethyl 3-phenylglycidate, 90%
| 121-39-1 |
|
2-Methyltetrahydrofuran-3-thiol
| 57124-87-5 |
|
Bis(2-methyl-3-furyl)disulphide, 98%
| 28588-75-2 |
|
2-Methylfuran-3-thiolacetate, 80%
| 55764-25-5 |
|
2-Tetrahydrofuroic acid, 99+%(gc)
| 16874-33-2 |
|
2,2,4,4,6,6-Hexamethyl-S-trithiane
| 828-26-2 |
|
MALEIC ACID, DISODIUM SALT, HYDRATE
| 371-47-1 |
|
Neurodye Di-8-ANEPPQ
| 0-01-1 |
|
Neurodye Di-12-ANEPPQ
| 0-01-1 |
|
Neurodye Di-4-ANEPPS
| 90134-00-2 |
|
Neurodye Di-8-ANEPPS
| 157134-33-7 |
|
Thallous formate, 98% (titr.)
| 992-98-3 |
|
Neurodye FM1-84
| 0-01-1 |
|
Neurodye RH-237
| 0-01-1 |
|
Neurodye RH-421
| 107610-19-5 |
|
Neurodye RH-795
| 0-01-1 |
|
Neurodye FM1-43
| 149838-22-2 |
|
Neurodye FM4-64
| 0-01-1 |
|
Neurodye FM2-10
| 0-01-1 |
|
ISOQUINOLINE-N-OXIDE
| 1532-72-5 |
|
1,3-Dithiolane-2,4,5-trithione, oligomer
| 123399-69-9 |
|
Dess-Martin periodinane, 15 wt% solution in dichloromethane
| 75-09-2 |
|
N-BENZYLIDENE-1-NAPTHYLAMINE, 97%
| 890-51-7 |
|
2-METHOXY-1-NAPHTHALENEMETHANOL
| 40696-22-8 |
|
(S)-(+)-Ibuprofen, 99%
| 51146-56-6 |
|
2-ETHOXYNAPHTHALENE, 98%
| 93-18-5 |
|
Trifluoromethanesulphinic acid potassium salt
| 41804-89-1 |
|
5-Chlorobarbituric acid
| 19645-77-3 |
|
n-Butyl (2R,3S)-(-)-2,3-epoxybutyrate, 98%
| 0-01-1 |
|
Diethyl (2R,3R)-(-)-2,3-epoxysuccinate, 98%
| 74243-85-9 |
|
Diethyl (2S,3S)-(+)-2,3-epoxysuccinate, 98%
| 73890-18-3 |
|
Benzo(e)pyrene, 99%
| 192-97-2 |
|
|